PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33551801-8	2020	Given these issues, in the present study we aimed to further explore SB290157"s pharmacological selectivity by screening the drug against three human anaphylatoxin receptors, C3aR, C5aR1 and C5aR2, using cell models.	SB 290157	69-77	complement C5a receptor 1	Homo sapiens	181-186